vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and ETHAN ALLEN INTERIORS INC (ETD). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $135.8M, roughly 2.0× ETHAN ALLEN INTERIORS INC). ETHAN ALLEN INTERIORS INC runs the higher net margin — 4.4% vs 1.4%, a 3.0% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs -4.8%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs -10.2%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Ethan Allen Interiors Inc. is an American manufacturer and retailer of home furnishings, incorporated in Delaware with executive offices in Danbury, Connecticut. As of June 30, 2023, the company reported net annual sales of $791.4 million.
ACAD vs ETD — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $135.8M |
| Net Profit | $3.6M | $5.9M |
| Gross Margin | — | 59.4% |
| Operating Margin | -1.7% | 4.8% |
| Net Margin | 1.4% | 4.4% |
| Revenue YoY | 9.7% | -4.8% |
| Net Profit YoY | — | -38.2% |
| EPS (diluted) | $0.02 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $135.8M | ||
| Q4 25 | $284.0M | $149.9M | ||
| Q3 25 | $278.6M | $147.0M | ||
| Q2 25 | $264.6M | $160.4M | ||
| Q1 25 | $244.3M | $142.7M | ||
| Q4 24 | $259.6M | $157.3M | ||
| Q3 24 | $250.4M | $154.3M | ||
| Q2 24 | $242.0M | $168.6M |
| Q1 26 | $3.6M | $5.9M | ||
| Q4 25 | $273.6M | $11.7M | ||
| Q3 25 | $71.8M | $10.5M | ||
| Q2 25 | $26.7M | — | ||
| Q1 25 | $19.0M | $9.6M | ||
| Q4 24 | $143.7M | $15.0M | ||
| Q3 24 | $32.8M | $14.7M | ||
| Q2 24 | $33.4M | $18.5M |
| Q1 26 | — | 59.4% | ||
| Q4 25 | 90.8% | 60.9% | ||
| Q3 25 | 92.2% | 61.4% | ||
| Q2 25 | 92.2% | 59.9% | ||
| Q1 25 | 91.7% | 61.2% | ||
| Q4 24 | 91.6% | 60.3% | ||
| Q3 24 | 92.5% | 60.8% | ||
| Q2 24 | 92.5% | 60.8% |
| Q1 26 | -1.7% | 4.8% | ||
| Q4 25 | 6.1% | 9.5% | ||
| Q3 25 | 12.8% | 6.8% | ||
| Q2 25 | 12.2% | 9.5% | ||
| Q1 25 | 7.9% | 7.7% | ||
| Q4 24 | 59.1% | 11.5% | ||
| Q3 24 | 12.6% | 11.4% | ||
| Q2 24 | 12.6% | 13.4% |
| Q1 26 | 1.4% | 4.4% | ||
| Q4 25 | 96.3% | 7.8% | ||
| Q3 25 | 25.8% | 7.1% | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | 7.8% | 6.7% | ||
| Q4 24 | 55.4% | 9.5% | ||
| Q3 24 | 13.1% | 9.5% | ||
| Q2 24 | 13.8% | 11.0% |
| Q1 26 | $0.02 | $0.23 | ||
| Q4 25 | $1.61 | $0.46 | ||
| Q3 25 | $0.42 | $0.41 | ||
| Q2 25 | $0.16 | $0.48 | ||
| Q1 25 | $0.11 | $0.37 | ||
| Q4 24 | $0.86 | $0.59 | ||
| Q3 24 | $0.20 | $0.57 | ||
| Q2 24 | $0.20 | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $66.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $473.7M |
| Total Assets | $1.6B | $723.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $66.6M | ||
| Q4 25 | $177.7M | $139.3M | ||
| Q3 25 | $258.0M | $123.6M | ||
| Q2 25 | $253.6M | $136.1M | ||
| Q1 25 | $217.7M | $172.9M | ||
| Q4 24 | $319.6M | $139.1M | ||
| Q3 24 | $155.1M | $135.9M | ||
| Q2 24 | $177.1M | $161.0M |
| Q1 26 | — | $473.7M | ||
| Q4 25 | $1.2B | $478.2M | ||
| Q3 25 | $917.3M | $475.5M | ||
| Q2 25 | $822.4M | $482.4M | ||
| Q1 25 | $765.2M | $479.2M | ||
| Q4 24 | $732.8M | $478.8M | ||
| Q3 24 | $577.2M | $474.7M | ||
| Q2 24 | $516.7M | $483.0M |
| Q1 26 | $1.6B | $723.3M | ||
| Q4 25 | $1.6B | $714.8M | ||
| Q3 25 | $1.3B | $737.1M | ||
| Q2 25 | $1.2B | $737.1M | ||
| Q1 25 | $1.1B | $738.7M | ||
| Q4 24 | $1.2B | $732.6M | ||
| Q3 24 | $976.9M | $737.7M | ||
| Q2 24 | $914.1M | $744.9M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
